Research and Development has been in medcanns’ DNA since its beginning with the
technification processes, and further implementation of ambitious hybridization programs,
using marker-assisted selective breeding technology.
In a changing reality in which scientific evidence on different cannabinoids - and
combinations of these - appears daily, the company ensures the continuous execution of
projects for the generation of new chemovars that seek higher concentrations of specific
active components, greater resistance to pests, and productivity improvement.
This way we can offer a diverse genetics portfolio of the highest quality, fully formalized
and registered, for our clients' cultivation operations.